Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study

Biomed Res Int. 2015:2015:621075. doi: 10.1155/2015/621075. Epub 2015 May 3.

Abstract

The use of stimulants for the purpose of pharmacological neuroenhancement (NE) among students is a subject of increasing public awareness. The risk of addiction development by stimulant use for NE is still unanswered. Therefore, face-to-face interviews were carried out among 18 university students experienced in the nonmedical use of methylphenidate and amphetamines for NE assessing aspects of addiction. Interviews were tape-recorded, verbatim-transcribed, and analyzed using a qualitative approach. The interviews showed that participants--the majority had current or lifetime diagnoses of misuse or addiction to alcohol or cannabis-reported an awareness of the risk of addiction development associated with stimulant use and reported various effects which may increase their likelihood of future stimulant use, for example, euphoric effects, increase of self-confidence, and motivation. They also cited measures to counteract the development of addiction as well as measures taken to normalize again after stimulant use. Students were convinced of having control over their stimulant use and of not becoming addicted to stimulants used for NE. We can conclude that behavior and beliefs of the students in our sample appear to be risky in terms of addiction development. However, long-term empirical research is needed to estimate the true risk of addiction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amphetamines / adverse effects*
  • Behavior, Addictive / chemically induced
  • Behavior, Addictive / epidemiology*
  • Central Nervous System Stimulants / adverse effects*
  • Female
  • Health Surveys
  • Humans
  • Male
  • Methylphenidate / adverse effects*
  • Students
  • Substance-Related Disorders / epidemiology*
  • Universities

Substances

  • Amphetamines
  • Central Nervous System Stimulants
  • Methylphenidate